Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy.
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Senescence, a durable form of growth arrest, represents a primary response to numerous anticancer therapies. Although the paradigm that senescence is “irreversible” has largely withstood the findings of tumor cell recovery from what has been termed “pseudo-senescence” or “senescence-like arrest,” a review of the literature suggests that therapy-induced senescence in tumor cells is not obligatorily a permanent cell fate. Consequently, we propose that senescence represents one avenue whereby tumor cells evade the direct cytotoxic impact of therapy, thereby allowing for prolonged survival in a dormant state, with the potential to recover self-renewal capacity and contribute to disease recurrence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SAPA might not always mark an irreversible end point for all cells within a population of presumably senescent cancer cells, and those that escape cell cycle arrest are likely to contribute to a clinical cancer relapse 5,178 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [178]
In the citing paper
“therefore, not surprisingly, senescent cancer cells are relatively prone to re-enter the cell cycle [109].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [109]
In the citing paper
“It has been found that cells which escape from senescence post-chemotherapy re-enter the cell cycle, are highly aggressive, chemo-resistant, and exhibit stem cell characteristics and can contribute to cancer recurrence (Milanovic et al., 2018; Saleh et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Saleh et al., 2019
In the citing paper
“and may provide a pathway for disease recurrence after cancer therapy.”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [20]
In the citing paper
“This induced senescence may be viewed as a cytostatic clinical response, but some of these therapy induced senescent cells may reactivate and lead to recurrence [20,21,22].”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [20]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · cited 1×
“This premise is supported by recent work by Campisi and colleagues that demonstrated that senescent cells contribute to cancer relapse (9).”
ResultSenescence-associated reprogramming promotes cancer stemness
Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., et al. (2018) · Nature · doi:10.1038/nature25167 · Cited by 1,131
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428
Two-Step Senescence-Focused Cancer Therapies
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.006 · Cited by 222
Tumor cell escape from therapy-induced senescence
Saleh, T., Tyutyunyk-Massey, L., Murray, G. F., Alotaibi, M. R., Kawale, A. S., Elsayed, Z., Henderson, S. C., Yakovlev, V., Elmore, L. W., Toor, A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.013 · Cited by 182
Self-citationStem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 169
Elmore, L. W., Di, X., Dumur, C., Holt, S. E., & Gewirtz, D. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1462 · Cited by 151
Self-citationPolyploidy road to therapy‐induced cellular senescence and escape
Wang, Q., Wu, P. C., Dong, D. Z., Ivanova, I., Chu, E., Zeliadt, S., Vesselle, H., & Wu, D. Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.27810 · Cited by 129
Waś, H., Barszcz, K., Czarnecka‐Herok, J., Kowalczyk, A., Bernaś, T., Użarowska, E., Koza, P., Klejman, A., Piwocka, K., Kaminska, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14066 · Cited by 71
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
“Senescent cells remain viable with alterations in metabolic activity and are usually resistant to apoptosis (Wang, 1995; Hampel et al., 2004; Marcotte et al., 2004; Ryu et al., 2007; Sanders et al., 2013; Childs et al., 2014; Zhu et al., 2015).”
BackgroundSenescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Prasanna, P. G., Citrin, D. E., Hildesheim, J., Ahmed, M. M., Venkatachalam, S., Riscuta, G., Xi, D., Zheng, G., Deursen, J. V., Goronzy, J., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab064 · Cited by 348
Self-citationTowards targeting of shared mechanisms of cancer metastasis and therapy resistance
Weiss, F., Lauffenburger, D., & Friedl, P. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00427-0 · Cited by 293
Metadata
- Authors
- Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A.
- Affiliations
- Hashemite University (JO)
- 2Department of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, Virginia.
- Virginia Commonwealth University (US)
- Corresponding author
- Gewirtz, David A.
- Venue
- Cancer Research
- Published
- 2019-03-15
- Volume
- 79
- Issue
- 6
- Pages
- 1044-1046
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2915423157
- Cited by
- 259
- References
- 10
- Citations by year
- 2026: 28 · 2025: 25 · 2024: 41 · 2023: 45 · 2022: 49 · 2021: 43 · 2020: 24 · 2019: 4
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- therapy-induced senescence, senescence escape, tumor dormancy, recurrence, self-renewal, growth arrest
- MeSH terms
- Combined Modality Therapy, Humans, Neoplasm Recurrence, Local, Neoplasms, Neoplasms, Second Primary, Cellular Senescence, Tumor Escape
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-3437
- The paper
- Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A. (2019). Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-3437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.